A prospective study comparing safety and efficacy of mycophenolate mofetil versus azathioprine in primary liver transplant recipients

Transplant Proc. 2000 Nov;32(7):2125-7. doi: 10.1016/s0041-1345(00)01599-2.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antilymphocyte Serum / therapeutic use
  • Azathioprine / adverse effects
  • Azathioprine / therapeutic use*
  • Cyclosporine / therapeutic use
  • Cytomegalovirus Infections / epidemiology
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Graft Rejection / epidemiology
  • Graft Rejection / prevention & control*
  • Graft Survival / drug effects
  • Graft Survival / physiology*
  • Hepatitis C / surgery
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Incidence
  • Liver Transplantation / immunology*
  • Liver Transplantation / mortality
  • Liver Transplantation / physiology
  • Male
  • Methylprednisolone / therapeutic use
  • Mycophenolic Acid / adverse effects
  • Mycophenolic Acid / analogs & derivatives
  • Mycophenolic Acid / therapeutic use*
  • Patient Selection
  • Postoperative Complications / epidemiology
  • Prospective Studies
  • Reoperation
  • Safety
  • Survival Rate
  • Time Factors

Substances

  • Antilymphocyte Serum
  • Immunosuppressive Agents
  • Cyclosporine
  • Mycophenolic Acid
  • Azathioprine
  • Methylprednisolone